(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CIVADERM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CIVADERM

ST13

US500000097310889

Class

10

Filing

97310889

Registration

7362729

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

04/23/2024

Trademark type

Word

Nice classes

10

Filing date

03/14/2022

Registration date

04/23/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/23/2024

Last transaction

04/23/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

08/01/2018

First use in commerce

09/04/2019

Drawing code

4

Owner type

03

Owner location

Durham, NC, US

Examiner

BROWN, BARBARA

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CivaTech Oncology Inc.

Representatives

CivaTech Oncology Inc.

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Medical device for treating cancer; Implantable radiation therapy devices consisting of sources packaged for surface application on the body

Publications

History of USPTO decisions and trademark events.

22 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/23/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/23/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/06/2024

PUBO

PUBLISHED FOR OPPOSITION

02/06/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/17/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/02/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/04/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/04/2023

ALIE

ASSIGNED TO LIE

12/04/2023

NREV

NOTICE OF REVIVAL - E-MAILED

06/29/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/29/2023

PETG

PETITION TO REVIVE-GRANTED

06/29/2023

PROA

TEAS PETITION TO REVIVE RECEIVED

06/29/2023

MAB2

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

04/19/2023

MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

04/18/2023

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

04/18/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/28/2022

GNRT

NON-FINAL ACTION E-MAILED

12/28/2022

CNRT

NON-FINAL ACTION WRITTEN

12/28/2022

DOCK

ASSIGNED TO EXAMINER

12/23/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/18/2022

NWAP

NEW APPLICATION ENTERED

03/17/2022

Continuous trademark protection

Get notified about every new filing that threatens CIVADERM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.